Trivarx Ltd has released a press release.
Medibio strengthens its IP protection
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Re-submission of FDA 510(k) application
- Consumer Mental Health App Development - Second Test Phase
- MEB Share Purchase Plan Closes Strongly Oversubscribed
- Supplementary Prospectus
- MEB Begins Implementation of ilumen In the United Kingdom
Later from TrivarX
- MEB Appoints R&CPMK As Communications Agency in the US
- Appendix 4E and Annual Report
- FDA Strategy and Regulatory Update
- MEB to Raise up to $5.7 million by way of a Placement & NREO
- Non-Renounceable Entitlement Offer Underwriting Update
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX